The global market for ophthalmic devices reached nearly $21.0 billion in 2017 and should reach $28.2 billion by 2022, at a compound annual growth rate (CAGR) of 6.1% for the period of 2017-2022
21 data tables
A comprehensive analysis of the market for ophthalmic devices by reviewing recent advances in diagnostic, surgical, and implantation devices that can be used to treat prevalent eye conditions
Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
Analysis of the recent advances in ophthalmic medical devices and their potential impact on the medical device industry
Evaluation of the market's dynamics, specifically growth drivers, restraints, and opportunities
Company profiles of major key players in the market, including Abbott Medical Optics, Alcon, Bausch & Lomb, Carl Zeiss Meditec, Johnson & Johnson, Quantel Medical, Topcon and Ziemer Ophthalmic Systems AG
This report on ophthalmic devices provides a brief description of the current status of the industry and recent developments. The report analyzes the market trends and identifies key medical and geographical challenges and rising opportunities in the developed and developing world. Finally, it will provide insights regarding new developments into ophthalmic and surgical devices that help to improve diagnosis and enhance the treatment of cataracts, glaucoma, refractory and retinal disorders.
Dr. Cheryl L. Barton has more than 10 years' experience in practical pharmaceutical research with a leading pharmaceutical company and has served as a Pan-European Pharmaceutical analyst with a European bank. Dr. C. L. Barton Ltd. aims to provide independent and tailor-made pharmaceutical thematic research to investment houses. Research reports combine independent scientific analysis with patient- and prescription-based models to forecast the potential sales growth of key developmental drugs and to isolate the key drivers within the pharmaceutical sector. For further information, visit www.pharmavision.co.uk.